These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8618513)
61. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin]. Lauterbach R; Kachlik P; Pawlik D; Bajorek I Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506 [TBL] [Abstract][Full Text] [Related]
62. Current controversies in the management of the anemia of prematurity. Bishara N; Ohls RK Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579 [TBL] [Abstract][Full Text] [Related]
63. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627 [TBL] [Abstract][Full Text] [Related]
64. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Ohls RK Paediatr Drugs; 2002; 4(2):111-21. PubMed ID: 11888358 [TBL] [Abstract][Full Text] [Related]
65. Erythropoietin to prevent transfusions in premature infants. Alfaleh K; Thabane L J Perinatol; 2005 Aug; 25(8):560. PubMed ID: 16047037 [No Abstract] [Full Text] [Related]
66. Neuroprotection with erythropoietin in preterm and/or low birth weight infants. Zhang J; Wang Q; Xiang H; Xin Y; Chang M; Lu H J Clin Neurosci; 2014 Aug; 21(8):1283-7. PubMed ID: 24650681 [TBL] [Abstract][Full Text] [Related]
67. ['Informed consent' and prerandomization]. de Craen AJ Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1301-3. PubMed ID: 10918907 [TBL] [Abstract][Full Text] [Related]
68. Informed versus randomised consent to clinical trials. Gallo C; Perrone F; De Placido S; Giusti C Lancet; 1995 Oct; 346(8982):1060-4. PubMed ID: 7564786 [TBL] [Abstract][Full Text] [Related]
69. Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease. Griffiths G; Lall R; Chatfield S; Short A; Mackay P; Williamson P; Brown J; Levene MI Arch Dis Child Fetal Neonatal Ed; 1997 May; 76(3):F190-2. PubMed ID: 9175950 [TBL] [Abstract][Full Text] [Related]
70. What has the Cochrane collaboration ever done for newborn infants? McGuire W; Fowlie PW; Soll RF Arch Dis Child Fetal Neonatal Ed; 2010 Jan; 95(1):F2-6. PubMed ID: 19414431 [No Abstract] [Full Text] [Related]
74. Pooling of trials is not appropriate in the case of heterogeneity. Bollen CW; Uiterwaal CS; van Vught AJ Arch Dis Child Fetal Neonatal Ed; 2006 May; 91(3):F233-4. PubMed ID: 16632654 [No Abstract] [Full Text] [Related]
75. Hard lessons from a randomised controlled trial. Jamrozik K Med J Aust; 2002 Mar; 176(6):248-9. PubMed ID: 11999252 [No Abstract] [Full Text] [Related]